Burke William P. Mr.
CIK 0001682069 Name as filed on the most recent filing
Filed as Burke William P. Mr. (29)· Burke Willaim P (1)
69 transaction lines · from 30 filings · filed 2017-11-16 to 2025-11-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Axogen, Inc. 8 filings
- ISSUER Miromatrix Medical Inc. 1 filings
- ISSUER Haemonetics Corp 21 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
69 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-11-11 |
Axogen, Inc. AXGN |
S, Open-market sale | 3,591 disposed | 24.02 | 86,248.64 | Form 4, filing 0000805928-25-000136 | |
| 2025-11-10 |
Axogen, Inc. AXGN |
S, Open-market sale | 19,227 disposed | 24.01 | 461,640.27 | Form 4, filing 0000805928-25-000136 | |
| 2025-11-06 |
Axogen, Inc. AXGN |
S, Open-market sale | 5,347 disposed | 24.01 | 128,370.78 | Form 4, filing 0000805928-25-000134 | |
| 2025-11-05 |
Axogen, Inc. AXGN |
S, Open-market sale | 11,431 disposed | 24.05 | 274,892.69 | Form 4, filing 0000805928-25-000134 | |
| 2025-10-30 |
Axogen, Inc. AXGN |
S, Open-market sale | 18,248 disposed | 23.00 | 419,704.00 | Form 4, filing 0000805928-25-000132 | |
| 2025-10-29 |
Axogen, Inc. AXGN |
S, Open-market sale | 20,436 disposed | 19.15 | 391,435.23 | Form 4, filing 0000805928-25-000132 | |
| 2025-10-29 |
Axogen, Inc. AXGN |
S, Open-market sale | 19,799 disposed | 22.00 | 435,578.00 | Form 4, filing 0000805928-25-000132 | |
| 2025-10-22 |
Axogen, Inc. AXGN |
S, Open-market sale | 1,457 disposed | 18.02 | 26,252.23 | Form 4, filing 0000805928-25-000125 | |
| 2025-10-06 |
Axogen, Inc. AXGN |
S, Open-market sale | 736 disposed | 18.00 | 13,248.74 | Form 4, filing 0000805928-25-000122 | |
| 2025-10-03 |
Axogen, Inc. AXGN |
S, Open-market sale | 14,571 disposed | 18.21 | 265,282.54 | Form 4, filing 0000805928-25-000119 | |
| 2025-10-03 |
Axogen, Inc. AXGN |
S, Open-market sale | 7,600 disposed | 18.21 | 138,367.12 | Form 4, filing 0000805928-25-000119 | |
| 2025-10-02 |
Axogen, Inc. AXGN |
S, Open-market sale | 7,620 disposed | 18.01 | 137,200.39 | Form 4, filing 0000805928-25-000119 | |
| 2025-10-02 |
Axogen, Inc. AXGN |
S, Open-market sale | 2,400 disposed | 18.01 | 43,224.00 | Form 4, filing 0000805928-25-000119 | |
| 2025-06-09 |
Axogen, Inc. AXGN |
S, Open-market sale | 4,073 disposed | 10.61 | 43,214.53 | Form 4, filing 0000805928-25-000083 | |
| 2023-08-23 |
Axogen, Inc. AXGN |
P, Open-market purchase | 10,000 acquired | 6.56 | 65,600.00 | Form 4, filing 0000805928-23-000106 | |
| 2023-03-10 |
Miromatrix Medical Inc. MIRO |
P, Open-market purchase | 31,250 acquired | 1.60 | 50,000.00 | Form 4, filing 0001415889-23-005631 | |
| 2021-08-23 |
Haemonetics Corp HAE |
S, Open-market sale | 22,667 disposed | 60.51 | 1,371,580.17 | Form 4, filing 0000899243-21-034143 | |
| 2021-07-01 |
Haemonetics Corp HAE |
S, Open-market sale | 4,293 disposed | 66.60 | 285,913.80 | Form 4, filing 0001127602-21-021568 | |
| 2021-06-14 |
Haemonetics Corp HAE |
S, Open-market sale | 190 disposed | 59.87 | 11,375.30 | Form 4, filing 0001127602-21-020050 | |
| 2021-06-07 |
Haemonetics Corp HAE |
S, Open-market sale | 411 disposed | 55.09 | 22,641.99 | Form 4, filing 0001127602-21-019522 | |
| 2021-05-19 |
Haemonetics Corp HAE |
S, Open-market sale | 238 disposed | 55.19 | 13,135.22 | Form 4, filing 0001127602-21-017677 | |
| 2021-05-17 |
Haemonetics Corp HAE |
S, Open-market sale | 219 disposed | 55.97 | 12,257.43 | Form 4, filing 0001127602-21-017257 | |
| 2020-10-26 |
Haemonetics Corp HAE |
S, Open-market sale | 1,161 disposed | 106.00 | 123,066.00 | Form 4, filing 0001127602-20-027619 | |
| 2020-06-16 |
Haemonetics Corp HAE |
S, Open-market sale | 6,146 disposed | 91.38 | 561,621.48 | Form 4, filing 0001127602-20-019790 | |
| 2020-06-16 |
Haemonetics Corp HAE |
S, Open-market sale | 5,259 disposed | 90.36 | 475,203.24 | Form 4, filing 0001127602-20-019790 | |
| 2020-06-16 |
Haemonetics Corp HAE |
S, Open-market sale | 1,209 disposed | 92.09 | 111,336.81 | Form 4, filing 0001127602-20-019790 | |
| 2020-06-15 |
Haemonetics Corp HAE |
S, Open-market sale | 9,720 disposed | 87.71 | 852,541.20 | Form 4, filing 0001127602-20-019790 | |
| 2020-06-12 |
Haemonetics Corp HAE |
S, Open-market sale | 197 disposed | 89.29 | 17,590.13 | Form 4, filing 0001127602-20-019790 | |
| 2020-06-08 |
Haemonetics Corp HAE |
S, Open-market sale | 639 disposed | 97.03 | 62,002.17 | Form 4, filing 0001127602-20-019376 | |
| 2020-05-15 |
Haemonetics Corp HAE |
S, Open-market sale | 221 disposed | 100.44 | 22,197.24 | Form 4, filing 0001127602-20-017235 | |
| 2019-10-29 |
Haemonetics Corp HAE |
S, Open-market sale | 1,448 disposed | 122.69 | 177,655.12 | Form 4, filing 0000899243-19-026127 | |
| 2019-10-28 |
Haemonetics Corp HAE |
S, Open-market sale | 1,155 disposed | 120.33 | 138,981.15 | Form 4, filing 0000899243-19-026127 | |
| 2019-10-25 |
Haemonetics Corp HAE |
S, Open-market sale | 6,905 disposed | 119.87 | 827,702.35 | Form 4, filing 0000899243-19-026127 | |
| 2019-10-25 |
Haemonetics Corp HAE |
S, Open-market sale | 4,326 disposed | 120.65 | 521,931.90 | Form 4, filing 0000899243-19-026127 | |
| 2019-10-09 |
Haemonetics Corp HAE |
S, Open-market sale | 11,448 disposed | 124.59 | 1,426,306.32 | Form 4, filing 0001127602-19-030383 | |
| 2019-10-09 |
Haemonetics Corp HAE |
S, Open-market sale | 8,356 disposed | 123.61 | 1,032,885.16 | Form 4, filing 0001127602-19-030383 | |
| 2019-10-09 |
Haemonetics Corp HAE |
S, Open-market sale | 2,900 disposed | 122.72 | 355,888.00 | Form 4, filing 0001127602-19-030383 | |
| 2019-10-08 |
Haemonetics Corp HAE |
S, Open-market sale | 18,950 disposed | 122.34 | 2,318,343.00 | Form 4, filing 0001127602-19-030383 | |
| 2019-10-01 |
Haemonetics Corp HAE |
S, Open-market sale | 3,070 disposed | 124.47 | 382,122.90 | Form 4, filing 0001127602-19-030039 | |
| 2019-10-01 |
Haemonetics Corp HAE |
S, Open-market sale | 1,670 disposed | 126.72 | 211,622.40 | Form 4, filing 0001127602-19-030039 | |
| 2019-10-01 |
Haemonetics Corp HAE |
S, Open-market sale | 1,309 disposed | 125.71 | 164,554.39 | Form 4, filing 0001127602-19-030039 | |
| 2019-10-01 |
Haemonetics Corp HAE |
S, Open-market sale | 648 disposed | 127.80 | 82,814.40 | Form 4, filing 0001127602-19-030039 | |
| 2019-10-01 |
Haemonetics Corp HAE |
S, Open-market sale | 467 disposed | 128.66 | 60,084.22 | Form 4, filing 0001127602-19-030039 | |
| 2019-06-12 |
Haemonetics Corp HAE |
S, Open-market sale | 190 disposed | 109.37 | 20,780.30 | Form 4, filing 0001127602-19-021560 | |
| 2019-06-07 |
Haemonetics Corp HAE |
S, Open-market sale | 411 disposed | 103.38 | 42,489.18 | Form 4, filing 0001127602-19-021235 | |
| 2018-11-08 |
Haemonetics Corp HAE |
S, Open-market sale | 13,056 disposed | 114.33 | 1,492,692.48 | Form 4, filing 0001127602-18-032653 | |
| 2018-10-26 |
Haemonetics Corp HAE |
S, Open-market sale | 779 disposed | 101.69 | 79,216.51 | Form 4, filing 0001127602-18-031291 | |
| 2018-06-25 |
Haemonetics Corp HAE |
S, Open-market sale | 5,717 disposed | 92.17 | 526,935.89 | Form 4, filing 0001127602-18-021961 | |
| 2018-06-25 |
Haemonetics Corp HAE |
S, Open-market sale | 970 disposed | 92.17 | 89,404.90 | Form 4, filing 0001127602-18-021961 | |
| 2018-06-07 |
Haemonetics Corp HAE |
S, Open-market sale | 425 disposed | 92.73 | 39,410.25 | Form 4, filing 0001127602-18-020488 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 2
- Open-market sale 67
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Burke William P. Mr., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001682069
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6